A randomized, double-blind, placebo-controlled, parallel-group, multicenter, event-driven phase III study to investigate the safety and efficacy of finerenone in addition to standard of care Read more about A randomized, double-blind, placebo-controlled, parallel-group, multicenter, event-driven phase III study to investigate the safety and efficacy of finerenone in addition to standard of care
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center, Event Driven Phase III Study to Investigate the Safety & Efficacy of Finerenone Read more about A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center, Event Driven Phase III Study to Investigate the Safety & Efficacy of Finerenone
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center, Event Driven Phase III Study to Investigate the Safety & Efficacy of Finerenone Read more about A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center, Event Driven Phase III Study to Investigate the Safety & Efficacy of Finerenone
Diabetes Incidence Prevalence and Medications Use Read more about Diabetes Incidence Prevalence and Medications Use
Epstein-Barr Virus Antisense Transcription - Progress Report Read more about Epstein-Barr Virus Antisense Transcription - Progress Report
P01: Noncoding RNAs in Herpersvinus Biology & AIDS Malignancies/TU's Project 2: "Epstein-Barr virus LMP2 IncRNAs" + Core B: "Virus RNA-seq & Bioinformatics Core" - SUB with UF Read more about P01: Noncoding RNAs in Herpersvinus Biology & AIDS Malignancies/TU's Project 2: "Epstein-Barr virus LMP2 IncRNAs" + Core B: "Virus RNA-seq & Bioinformatics Core" - SUB with UF
Center for Translational Viral Oncology (CTVO) Read more about Center for Translational Viral Oncology (CTVO)
